Company Filing History:
1 out of 154 
1 out of 33 
1 out of 69 Years Active: 2025
Title: Christel Goudot: Innovator in Engineered Immune Cells
Introduction
Christel Goudot is a prominent inventor based in Le Blanc Mesnil, France. She has made significant contributions to the field of immunology, particularly in the engineering of immune cells for therapeutic applications. Her innovative work focuses on enhancing the efficacy of immune responses against cancer.
Latest Patents
Christel Goudot holds a patent titled "Immune cells defective for SUV39H1." This invention relates to engineered immune cells that are defective for Suv39h1. The engineered immune cells also include a genetically engineered antigen receptor that specifically binds to a target antigen. The patent outlines a method for obtaining these genetically engineered immune cells, which involves inhibiting the expression and/or activity of Suv39h1. Additionally, the method may include introducing a genetically engineered antigen receptor into the immune cell. This invention is particularly relevant for adoptive therapy in cancer treatment.
Career Highlights
Throughout her career, Christel Goudot has worked with esteemed institutions such as the Institut Curie and the Institut National de la Santé et de la Recherche Médicale (Inserm). Her research has contributed to advancements in cancer therapies and the understanding of immune cell engineering.
Collaborations
Christel has collaborated with notable colleagues in her field, including Sebastian Amigorena and Eliane Piaggio. These collaborations have further enriched her research and innovation in immune cell engineering.
Conclusion
Christel Goudot's work in the field of engineered immune cells represents a significant advancement in cancer therapy. Her innovative patent and collaborations highlight her commitment to improving therapeutic strategies in immunology.